ロード中...

Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types

PURPOSE: The efficacy and safety of regorafenib have been demonstrated in phase 3 trials for multiple tumor types, including metastatic colorectal cancer (mCRC) (CORRECT [NCT01103323]; CONCUR [NCT01584830]), advanced gastrointestinal stromal tumor (GIST) (GRID [NCT01271712]), and hepatocellular carc...

詳細記述

保存先:
書誌詳細
出版年:Cancer Manag Res
主要な著者: Hofheinz, Ralf-Dieter, Bruix, Jordi, Demetri, George D, Grothey, Axel, Marian, Marisca, Bartsch, Jennifer, Odom, Dawn
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285228/
https://ncbi.nlm.nih.gov/pubmed/34285574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S305939
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!